Improving Outcomes With PARP Inhibitors in Ovarian Cancer

Join the experts for this online activity on PARP inhibitors in ovarian cancer featuring interactive case vignettes and dynamic in-page polling questions and 2 podcasts all linked to a downloadable slideset.

This educational program  is intended for clinicians practicing medicine outside of the United States.

Share

Program Content

Activities

Ovarian Biomarker Testing
Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 02, 2020

Expires: October 01, 2021

Podcast Pearl: Ovarian Biomarker Testing
Biomarkers in Ovarian Cancer: Expert Discussion of BRCA Testing and Beyond
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 09, 2020

Expires: October 08, 2021

Ovarian: First-line Therapy
Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: October 02, 2020

Expires: October 01, 2021

Podcast Pearl: Ovarian: First-line Therapy
Biomarkers in Ovarian Cancer: Expert Discussion of Options for First-line Maintenance Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 09, 2020

Expires: October 08, 2021

Activities

Ovarian Cancer PARPi Therapy
Current Landscape in Ovarian Cancer: PARP Inhibitors and Targeted Therapy
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2020

Expires: December 02, 2021

Activities

OC: Current Landscape
Current Landscape in Ovarian Cancer: PARP Inhibitors and Targeted Therapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 03, 2020

Expires: December 02, 2021

Supporters

GlaxoSmithKline LLC